Telix Pharmaceuticals
The Quality Control Lead is a site-based role responsible for coordinating and performing Quality Control activities supporting clinical and commercial radiopharmaceutical production at the Wilkes-Barre facility. The role provides technical expertise in analytical method development and validation, specifications, stability programs, routine testing, laboratory investigations, equipment qualification, and GMP documentation. During the facility’s build and validation phase, the role supports the commissioning, qualification, validation, and operational readiness of the QC laboratory.
Headquarters
North Melbourne, Victoria, Australia
Company Size
201-500 employees
Founded
2015
Telix Pharmaceuticals is a global, commercial‑stage biopharmaceutical company developing diagnostic and therapeutic “theranostic” products that use targeted radiation to detect and treat cancer. It advances radiopharmaceuticals through clinical development, regulatory approval, manufacturing and commercialisation to bring imaging agents and targeted therapies to patients. Telix works with the nuclear medicine community and international partners to scale access and improve outcomes. Its stated mission is to help patients with cancer live longer with better quality lives.
TLX DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
Dec 14, 2025
Telix Pharmaceiuticals sees sell-off on back of class actions | ASX:TLX
Nov 13, 2025
Pharma groups rush to calm investor fears over Trump’s tariff hit
Sep 26, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Telix Pharmaceuticals.
Telix Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.
The Market Doesn't Like What It Sees From Telix Pharmaceuticals Limited's (ASX:TLX) Revenues Yet As Shares Tumble 26%
Dec 31, 2025
QC Specialist / Senior QC Specialist
GSK plc
Quality Control Analyst (Multiple Openings)
CRISPR Therapeutics
QC Specialist
GMP technologies
QC Scientist I
Cellipont Bioservices
Lab Technician QC - Late Phase 100% (w/m/d) befristet 12 Monate
Bachem Holding AG
QC Analyst Training Program Scientist
WuXi Biologics